INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 81 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2016. The put-call ratio across all filers is 6.55 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $404,000 | +100.0% | 212,651 | +110.7% | 0.03% | +136.4% |
| Q1 2017 | $202,000 | -78.1% | 100,930 | -33.1% | 0.01% | -79.6% |
| Q4 2016 | $921,000 | -32.5% | 150,930 | +4.8% | 0.05% | +5.9% |
| Q3 2016 | $1,365,000 | +72.3% | 144,002 | +35.3% | 0.05% | +24.4% |
| Q2 2016 | $792,000 | -8.1% | 106,454 | -8.6% | 0.04% | -4.7% |
| Q1 2016 | $862,000 | -13.2% | 116,454 | +32.9% | 0.04% | -21.8% |
| Q4 2015 | $993,000 | -4.0% | 87,652 | -20.3% | 0.06% | +27.9% |
| Q3 2015 | $1,034,000 | – | 110,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
| RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
| Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
| NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
| FT Options LLC | 26,421 | $299,000 | 0.22% |
| EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
| Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |